Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereotactic body radiation therapy or systemic therapy alone.

Front Oncol · 2023 · PMC10711055 · PMID 38090505

Europe PMC DOI

hedged sentence

0.0538

closest p · 1.1× alpha

0.0538

boldest claim

The sentences

did not reach statistical significanceP =0.0538so close (0.05 < p ≤ 0.1)

On MVA, receipt of SBRT predicted for improved OS (HR=0.748, 95%CI 0.588-0.951; P =0.0178) and receipt of IO demonstrated a trend towards improved OS, although this did not reach statistical significance (HR=0.859, 95%CI 0.735-1.003; P =0.0538).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.